Pet Drug Reports

Drugs by active ingredient › Praziquantel + Pyrantel Pamoate

Drug · combination of 2 active ingredients

Praziquantel + Pyrantel Pamoate: adverse event reports

All products with this ingredient combination · 2 FDA-approved applications in the Green Book

5,037reports naming this combination, 1995–20260.4% of all reports · about 166 a year
206reports, 12 months to March 2026229 in the 12 months before
37.4%classed serious, as reportedof 4,159 reports stating it
6.6%record death or euthanasia, as reported333 reports
72.4%of reports concern dogs0.4% of all dog reports

FDA has received 5,037 adverse event reports in which a drug is recorded with the combination praziquantel and pyrantel pamoate as its active ingredients, from December 1995 to March 2026. The Green Book lists 2 FDA-approved applications with exactly this combination.

openFDA masks the brand and manufacturer in every report, so these figures describe the ingredient combination across all products and cannot be attributed to a brand.

In the 12 months to March 2026, 206 reports named it, down 10% from 229 in the 12 months before. Recent months are provisional: fDA posts reports quarterly with a delay of three to six months, so the newest months are incomplete and usually grow in later releases. Over its whole reporting history that is about 166 reports a year and 0.4% of all 1,357,245 reports (0.4% of all dog reports). How many animals received it is not published, so a count says nothing about how often a problem occurs per dose.

Reporters most often listed vomiting (38.3%), lethargy (18.4%) and diarrhoea (12.5%). A report can list several signs, so shares add to more than 100%; 1,007 different terms appear across these reports. Vomiting appears in 38.3% of these reports, a larger share than in the pooled reports for every drug containing praziquantel (21.3%).

72.4% of reports concern dogs. Of reports that state seriousness, 37.4% were classed as serious, and 6.6% of all reports record a death or euthanasia as an outcome, as reported. FDA has not necessarily determined whether any drug played a part.

Monthly reports by species, five years

Dog916 · peak 28
Apr 2021: 20May 2021: 16Jun 2021: 15Jul 2021: 23Aug 2021: 17Sep 2021: 13Oct 2021: 20Nov 2021: 18Dec 2021: 14Jan 2022: 13Feb 2022: 20Mar 2022: 23Apr 2022: 13May 2022: 17Jun 2022: 14Jul 2022: 19Aug 2022: 28Sep 2022: 21Oct 2022: 14Nov 2022: 15Dec 2022: 13Jan 2023: 20Feb 2023: 19Mar 2023: 15Apr 2023: 10May 2023: 14Jun 2023: 14Jul 2023: 12Aug 2023: 27Sep 2023: 11Oct 2023: 16Nov 2023: 11Dec 2023: 15Jan 2024: 28Feb 2024: 14Mar 2024: 9Apr 2024: 14May 2024: 13Jun 2024: 10Jul 2024: 18Aug 2024: 13Sep 2024: 17Oct 2024: 22Nov 2024: 8Dec 2024: 10Jan 2025: 17Feb 2025: 8Mar 2025: 12Apr 2025: 15May 2025: 8Jun 2025: 20Jul 2025: 20Aug 2025: 16Sep 2025: 10Oct 2025: 12Nov 2025: 13Dec 2025: 7Jan 2026: 12Feb 2026: 14Mar 2026: 62022202320242025
Cat249 · peak 13
Apr 2021: 6May 2021: 4Jun 2021: 4Jul 2021: 9Aug 2021: 5Sep 2021: 3Oct 2021: 3Dec 2021: 3Jan 2022: 7Feb 2022: 2Mar 2022: 1Apr 2022: 4May 2022: 5Jun 2022: 2Jul 2022: 2Aug 2022: 8Sep 2022: 3Oct 2022: 5Nov 2022: 4Dec 2022: 4Jan 2023: 6Feb 2023: 3Mar 2023: 2May 2023: 3Jun 2023: 7Jul 2023: 5Aug 2023: 2Sep 2023: 4Oct 2023: 8Nov 2023: 3Dec 2023: 1Jan 2024: 2Feb 2024: 13Mar 2024: 3Apr 2024: 1May 2024: 2Jun 2024: 4Jul 2024: 4Aug 2024: 3Sep 2024: 5Oct 2024: 6Nov 2024: 6Dec 2024: 6Jan 2025: 4Feb 2025: 1Mar 2025: 9Apr 2025: 1May 2025: 4Jun 2025: 4Jul 2025: 12Sep 2025: 2Oct 2025: 6Nov 2025: 6Dec 2025: 1Jan 2026: 7Feb 2026: 6Mar 2026: 32022202320242025
Horse0 · peak 1
2022202320242025
Other63 · peak 5
Apr 2021: 1Jun 2021: 1Jul 2021: 2Aug 2021: 1Sep 2021: 2Dec 2021: 1Jan 2022: 3Feb 2022: 1Mar 2022: 1Jun 2022: 1Jul 2022: 3Aug 2022: 2Oct 2022: 2Nov 2022: 5Dec 2022: 5Feb 2023: 2Mar 2023: 1May 2023: 1Jun 2023: 5Aug 2023: 1Sep 2023: 2Mar 2024: 3Apr 2024: 1Jun 2024: 2Jul 2024: 2Oct 2024: 3Nov 2024: 3Dec 2024: 1Jan 2025: 1Feb 2025: 2Mar 2025: 1Aug 2025: 12022202320242025

Reports by the month FDA received them. Each panel has its own scale; the peak month is printed at the top right. The newest months are incomplete because FDA posts reports with a delay of three to six months.

Reports by year received

02324641995: 119951996: 61997: 111998: 1319981999: 152000: 132001: 1120012002: 312003: 122004: 1620042005: 222006: 132007: 3820072008: 482009: 1482010: 25320102011: 2972012: 3822013: 46420132014: 3562015: 2502016: 17220162017: 2982018: 2832019: 27520192020: 3032021: 2792022: 28020222023: 2402024: 2462025: 21320252026: 48

2026 covers reports received through March 2026 only.

Signs listed in reports

share of praziquantel + pyrantel pamoate reports listing the termall drugs containing praziquantelall dog reports

  1. Vomiting38.3%1,930
  2. Lethargy[unusually tired or inactive]18.4%926
  3. Diarrhoea[diarrhea]12.5%631
  4. Ataxia[unsteady, uncoordinated movement]10.7%537
  5. Anorexia[not eating]6.4%323
  6. Not eating5.5%276
  7. Death4.7%239
  8. Emesis[vomiting]4.4%220
  9. Depression[dull, quiet or withdrawn]4.3%218
  10. Bloody diarrhoea[diarrhea with blood]4.1%204
  11. Behavioural disorder NOS[behaviour change, type not specified]4%202
  12. Emesis (multiple)[vomiting more than once]3.3%165
  13. Shaking3%150
  14. Overdose[more than the labelled amount was given]2.7%138
  15. Lack of efficacy (endoparasite) - tapeworm[the product did not have the expected effect: tapeworms]2.7%135
  16. Vocalisation[crying out or unusual noise]2.4%119
  17. Hypersalivation[drooling]2.3%115
  18. Seizure NOS[seizure, type not specified]2%100
  19. Accidental exposure[exposure that was not intended]1.8%90
  20. Panting1.7%88
  21. Underdose[less than the labelled amount was given]1.7%86
  22. Weakness1.6%79
  23. Lack of efficacy (endoparasite) - hookworm[the product did not have the expected effect: hookworms]1.5%77
  24. Death by euthanasia[the animal was euthanized]1.5%75
  25. Other abnormal test result NOS[abnormal laboratory result, type not specified]1.4%71

Top 30 of 1,007 coded terms (VeDDRA, the veterinary reporting dictionary; plain-language gloss in brackets). One report can list several terms. The ticks show how often the same term appears in a wider pool of reports; they describe the reports, and FDA cautions that such figures cannot be used to estimate risk or to compare one product with another. openFDA masks brand and manufacturer names in adverse event records, so the reports counted here cannot be attributed to a particular brand.

Outcomes and report types

Outcome recorded in the report

Recovered/Normal33.5%1,685
Recovered with Sequela0.3%14
Ongoing4.4%224
Died5.4%271
Euthanized1.2%62
Outcome Unknown39.3%1,982

What kind of report it was

Safety issue88.3%4,448
Lack of expected effectiveness5.2%260
Both safety and lack of expected effectiveness3.9%197
Manufacturing or product defect2.6%131
Other0%1

Coloured bar: reports naming praziquantel + pyrantel pamoate. Grey bar: all 1,357,245 reports in the database. Outcomes are the status at the time of the last report, as stated by the reporter; a report covering several animals can carry more than one outcome. FDA has not necessarily determined whether any drug played a part in any outcome.

Species and breeds in the reports

Species

Dog72.4%3,648
Cat24.8%1,249
Human exposure0.6%29
Other0%2

Single-breed animals

Breed shares follow how common each breed is. Crossbred animals and reports with no breed stay in the species figure only.

Age, weight and route

Age of the animal

Under 1 year34.7%1,749
1 to 3 years23.6%1,187
4 to 7 years15.2%764
8 to 11 years9.5%476
12 years and over6.9%348
Age not given10.2%513

Weight of the animal

Under 5 kg (11 lb)39%1,963
5 to 9.9 kg (11–22 lb)21.9%1,105
10 to 24.9 kg (22–55 lb)16.1%811
25 to 44.9 kg (55–99 lb)9%453
45 kg and over (99 lb+)1.7%85
Weight not given12.3%620

Route of administration stated in reports: oral (4,670), topical (11), ophthalmic (3), subcutaneous (2), epidural (1).

In context

MeasurePraziquantel + Pyrantel PamoateAll drugs containing praziquantelAll dog reportsAll reports
Reports5,03783,303985,6751,357,245
Share of that pool's reports naming this drug—6%0.4%0.4%
Classed serious, of reports stating it37.4%24.4%38.3%38.6%
Death or euthanasia recorded, per 1,000 reports66.1325563.8
Filed as lack of expected effectiveness (wholly or partly)9.1%——23%
Top term, share of reportsVomiting 38.3%21.3%19.7%—

The praziquantel pool is every report naming praziquantel alone or in any combination; this combination accounts for 6% of it. Shares are of reports, not of animals treated. The number of doses sold is not public, so none of these figures is a rate of occurrence, and differences between columns reflect which animals receive a drug and who reports as much as anything else.

Other ingredient sets sharing an ingredient

Active ingredientsReportsLatest 12 months
Ivermectin + Pyrantel Pamoate161,6434,876
Pyrantel Pamoate + Sarolaner52,06610,626
Milbemycin Oxime + Praziquantel33,1162,477
Ivermectin + Praziquantel + Pyrantel Pamoate8,999100
Afoxolaner + Moxidectin + Pyrantel Pamoate8,7694,349
Febantel + Praziquantel + Pyrantel Pamoate7,061415
Lufenuron + Milbemycin Oxime + Praziquantel6,704761
Emodepside + Praziquantel6,109175
Pyrantel Pamoate5,867250
Praziquantel3,960336
Lufenuron + Praziquantel3,5261
Ivermectin + Praziquantel3,38247

Listed for navigation, ordered by report count. FDA states that these data "cannot be used to estimate the risk associated with the product or compare one drug or device product with another": drugs differ in formulation, in the animals they are given to, in sales volume and in years on the market. A report's ingredient field can be incomplete, so reports about one product may sit under more than one set.

FDA-approved products containing this combination (Green Book)

Reference information, not report statistics. openFDA masks brand and manufacturer names in adverse event records, so the reports counted here cannot be attributed to a particular brand. The list below is the FDA Green Book as of 30 Sep 2026; nothing on this page says which of these products, if any, a report concerned.

Trade nameActive ingredientsSponsorApproved forApplication
Drontal TabletsPraziquantel, Pyrantel PamoateElanco US Inc.CatsNADA 141-008
Virbantel; Worm X PlusPraziquantel, Pyrantel PamoateVirbac AH, Inc.DogsNADA 141-261

Species are the major species the Green Book search lists for the application ("—" where it lists another species or none). Approval dates are not part of the Green Book listing files and are not shown. Pioneer applications (NADA) come first, then generics (ANADA).

Questions about praziquantel + pyrantel pamoate reports

How many adverse event reports has FDA received for the combination praziquantel and pyrantel pamoate?

5,037 reports record a drug with the combination praziquantel and pyrantel pamoate as its active ingredients in the openFDA release of 28 Sep 2026, covering reports received through March 2026. 206 of them arrived in the latest 12 months.

Which brand do these reports concern?

That cannot be known from the public data. openFDA masks brand and manufacturer names in adverse event records, so the reports counted here cannot be attributed to a particular brand. The Green Book lists 2 approved applications with this combination; the reference list on this page names them without any counts.

What signs are reported most often?

vomiting (38.3%), lethargy (18.4%), diarrhoea (12.5%), ataxia (10.7%) and anorexia (6.4%). These are the coded terms listed in reports; several can appear in one report, and a term's presence is not a finding that the drug was responsible.

Which species and breeds appear in these reports?

dog (72.4%), cat (24.8%) and human exposure (0.6%). Among single-breed animals the most frequent labels are Domestic Shorthair, Chihuahua, Domestic and Pit Bull; popular breeds appear often in any drug's reports because there are more of them.

Are reports rising?

206 reports in the 12 months to March 2026, down 10% from 229 in the 12 months before. FDA posts reports quarterly with a delay of three to six months, so the newest months are incomplete and usually grow in later releases. Counts also move with sales, publicity and time on the market.

Do these reports show that praziquantel + pyrantel pamoate harms pets?

Report counts cannot show that. FDA states that "there is no certainty that the reported drug or device caused the adverse event" and that the event "may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources." FDA also notes that commonly used products may have more reports simply because more animals receive them.

Are these the side effects of praziquantel + pyrantel pamoate?

They are signs listed in reports, not an established list of side effects. The adverse reactions observed in studies are printed on each product's FDA-approved label, which a veterinarian can go through with you. This page is a record of what was reported to FDA.

How do I report a problem with an animal drug?

FDA asks owners and veterinarians to call the drug company first (the number is on the label); companies must pass reports to FDA. Reports can also go directly to FDA on Form FDA 1932a. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Animal & Veterinary adverse event bulk files released 28 Sep 2026, which hold reports FDA's Center for Veterinary Medicine received through 31 Mar 2026. openFDA masks brand and manufacturer names in these files, so drugs are counted by the active ingredients each record discloses and no figure is attributed to a brand, application or company. Ingredient names, and the separate reference lists of approved products, follow the FDA Green Book as of 30 Sep 2026. Drug entries are grouped by the active ingredients their unmasked ingredient field discloses; the application number that records also carry is not used. No report text, lot numbers or reporter details are published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.